Cargando…

Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer

Driver-directed therapeutics have revolutionized cancer treatment, presenting similar or better efficacy compared to traditional chemotherapy and substantially improving quality of life. Despite significant advances, targeted therapy is greatly limited by resistance acquisition, which emerges in nea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadeghi, Mohammad Mojtaba, Salama, Mohamed F., Hannun, Yusuf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197251/ https://www.ncbi.nlm.nih.gov/pubmed/34073823 http://dx.doi.org/10.3390/ijms22115527

Ejemplares similares

PKCα is required for Akt-mTORC1 activation in Non-Small Cell Lung Carcinoma (NSCLC) with EGFR mutation
por: Salama, Mohamed F., et al.
Publicado: (2019)

The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
por: Golding, Brandon, et al.
Publicado: (2018)

Sustained Activation of Protein Kinase C Induces Delayed Phosphorylation and Regulates the Fate of Epidermal Growth Factor Receptor
por: Liu, Mengling, et al.
Publicado: (2013)

Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer
por: Tong, Xuexia, et al.
Publicado: (2019)

Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression
por: Liu, Liu, et al.
Publicado: (2019)

Transcriptional Regulation of Sphingosine Kinase 1
por: Bonica, Joseph, et al.
Publicado: (2020)

Protein kinase C in heart failure: a therapeutic target?
por: Palaniyandi, Suresh Selvaraj, et al.
Publicado: (2009)

Protein kinase Cα: disease regulator and therapeutic target
por: Konopatskaya, Olga, et al.
Publicado: (2010)

Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer
por: Velazquez, Fabiola N., et al.
Publicado: (2021)

Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga, Noriaki, et al.
Publicado: (2015)

Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
por: Halvorsen, Ann Rita, et al.
Publicado: (2020)

Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
por: Fukui, Takafumi, et al.
Publicado: (2022)

Protein Kinase C iota as a Therapeutic Target in Alveolar Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2012)

Pyruvate kinase M2 may be a therapeutic target in a mouse model of human non-small cell lung cancer
por: Suzuki, Akiko, et al.
Publicado: (2015)

Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target
por: Aboubakar Nana, Frank, et al.
Publicado: (2019)

RANBP9 as potential therapeutic target in non-small cell lung cancer
por: Tessari, Anna, et al.
Publicado: (2020)

Activation of p38 Mitogen-Activated Protein Kinase in Gaucher’s Disease
por: Kitatani, Kazuyuki, et al.
Publicado: (2015)

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
por: Kawano, Takahito, et al.
Publicado: (2022)

Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy
por: Lv, Die, et al.
Publicado: (2021)

Evaluating intrinsic and non-intrinsic cancer risk factors
por: Wu, Song, et al.
Publicado: (2018)

Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets
por: Chen, Jing, et al.
Publicado: (2014)

Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
por: Scagliotti, Giorgio, et al.
Publicado: (2010)

Co-ordinated activation of classical and novel PKC isoforms is required for PMA-induced mTORC1 activation
por: Liu, Mengling, et al.
Publicado: (2017)

Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer
por: McCarroll, Joshua A., et al.
Publicado: (2015)

A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells
por: Ghaderi, Amineh, et al.
Publicado: (2023)

Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
por: Botting, Gregory M., et al.
Publicado: (2015)

Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis
por: Zhao, Xin, et al.
Publicado: (2022)

Xanthine oxidase, a therapeutic target of realgar for non-small cell lung cancer
por: Guo, Rui, et al.
Publicado: (2023)

Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)
por: Zhou, Lei, et al.
Publicado: (2023)

P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment
por: Wada, Masayuki, et al.
Publicado: (2017)

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
por: Plowright, L, et al.
Publicado: (2009)

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
por: Ryan, Sarah-Louise, et al.
Publicado: (2021)

Long non-coding RNAs as potential therapeutic targets in non-small cell lung cancer (Review)
por: Tang, Peiyu, et al.
Publicado: (2023)

Targeting Protein Kinase C for Cancer Therapy
por: He, Sijia, et al.
Publicado: (2022)

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2019)

Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
por: Mirzapoiazova, Tamara, et al.
Publicado: (2021)

Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment
por: Shintani, Yasushi, et al.
Publicado: (2023)

Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma
por: Hasan, Gulam Mustafa, et al.
Publicado: (2023)

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells
por: Zito, Christopher R., et al.
Publicado: (2012)

Molecular Mechanisms Contributing to Resistance to Tyrosine Kinase-Targeted Therapy for Non-Small Cell Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_888rg83uisat1fifsq8dv7kukh